Legato Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,492
Closed -$304K 590
2024
Q4
$304K Sell
13,492
-1,090
-7% -$24.5K 0.04% 495
2024
Q3
$372K Buy
+14,582
New +$372K 0.05% 479